$98M office campus sale sets new high-water mark for county
The eye-popping price signals that a turnaround is taking hold in the Ventura County office market, which has suffered from high vacancy rates in a depressed job market, industry insiders say.
Amgen reports positive trial results for high-cholesterol treatment
The portion of Amgen’s Phase 3 trial of evolocumab that evaluated patients with high cholesterol who cannot tolerate statins has met goals related to percent reduction of low-density lipoprotein cholesterol.
Teledyne shares dip despite jump in Q4 profits
Shares of defense and industrial conglomerate Teledyne Technologies sank 1.6 percent in midday trading on Thursday despite higher sales and profits from the Thousand Oaks-based firm.
Amgen enters into deals for colon cancer, IBD treatments
Thousand Oaks-based Amgen has entered into two new collaborations, one involving treatment for colon cancer and another regarding therapies for inflammatory bowel disease.
Amgen’s chief financial officer to depart
Chief Financial Officer Jonathan M. Peacock is leaving Amgen to pursue broader career opportunities, the company announced. Michael A. Kelly has been named acting CFO.
